0001104659-21-020193.txt : 20210211
0001104659-21-020193.hdr.sgml : 20210211
20210211063523
ACCESSION NUMBER: 0001104659-21-020193
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210210
FILED AS OF DATE: 20210211
DATE AS OF CHANGE: 20210211
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Akers Joseph A
CENTRAL INDEX KEY: 0001379888
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-13341
FILM NUMBER: 21616593
MAIL ADDRESS:
STREET 1: 630 FIFTH AVENUE, 22ND FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10111
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TITAN PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000910267
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 943171940
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 OYSTER POINT BLVD
STREET 2: SUITE 505
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 6502444990
MAIL ADDRESS:
STREET 1: 400 OYSTER POINT BLVD
STREET 2: SUITE 505
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
tm216217-2_4.xml
OWNERSHIP DOCUMENT
X0306
4
2021-02-10
0
0000910267
TITAN PHARMACEUTICALS INC
TTNP
0001379888
Akers Joseph A
102 W. GLENHAVEN DRIVE
PHOENIX
AZ
85045
1
0
0
0
Option to Purchase Common Stock
4.02
2021-02-10
4
A
0
25000
0
A
2021-08-10
2031-02-10
Common Stock
25000
25000
D
/S/ Joseph A. Akers
2021-02-10